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Abstract
Background: Population health measurements are recognised as appropriate tools to support public health
monitoring. Yet, there is still a lack of tools that offer a basis for policy appraisal and for foreseeing impacts on
health equity. In the context of persistent regional inequalities, it is critical to ascertain which regions are
performing best, which factors might shape future health outcomes and where there is room for improvement.
Methods: Under the EURO-HEALTHY project, tools combining the technical elements of multi-criteria value models
and the social elements of participatory processes were developed to measure health in multiple dimensions and
to inform policies. The flagship tool is the Population Health Index (PHI), a multidimensional measure that evaluates
health from the lens of equity in health determinants and health outcomes, further divided into sub-indices.
Foresight tools for policy analysis were also developed, namely: (1) scenarios of future patterns of population health
in Europe in 2030, combining group elicitation with the Extreme-World method and (2) a multi-criteria evaluation
framework informing policy appraisal (case study of Lisbon). Finally, a WebGIS was built to map and communicate
the results to wider audiences.
Results: The Population Health Index was applied to all European Union (EU) regions, indicating which regions are
lagging behind and where investments are most needed to close the health gap. Three scenarios for 2030 were
produced – (1) the ‘Failing Europe’ scenario (worst case/increasing inequalities), (2) the ‘Sustainable Prosperity’
scenario (best case/decreasing inequalities) and (3) the ‘Being Stuck’ scenario (the EU and Member States maintain
the status quo). Finally, the policy appraisal exercise conducted in Lisbon illustrates which policies have higher
potential to improve health and how their feasibility can change according to different scenarios.
Conclusions: The article makes a theoretical and practical contribution to the field of population health.
Theoretically, it contributes to the conceptualisation of health in a broader sense by advancing a model able to
integrate multiple aspects of health, including health outcomes and multisectoral determinants. Empirically, the
model and tools are closely tied to what is measurable when using the EU context but offering opportunities to be
upscaled to other settings.
Keywords: Health equity, European Union regions, Geographic inequalities, Population Health Index, Participatory
approach, Foresight, Scenarios, Policy evaluation, WebGIS
© The Author(s). 2020 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
* Correspondence: paulasantana.coimbra@gmail.com
1Department of Geography and Tourism, Faculty of Arts and Humanities,
University of Coimbra, Colégio S. Jerónimo, Largo D. Dinis, 3001-401
Coimbra, Portugal
2CEGOT-UC, Centre of Studies in Geography and Territorial Planning,
University of Coimbra, Coimbra, Portugal
Full list of author information is available at the end of the article
Santana et al. Health Research Policy and Systems           (2020) 18:18 
https://doi.org/10.1186/s12961-020-0526-y
Background
The increasing complexity in measuring health inequal-
ities requires new instruments and more meaningful
information at the regional and community level.
Considerable advances in knowledge have identified
the key driving forces that are likely to influence health
and well-being [1–6]. However, in terms of assessment
methods [7, 8], there is still a lack of comparable mea-
sures able to provide a holistic assessment of population
health based on the multiple determinants involved,
ones which would then be applied across Europe [9],
particularly at the regional and local level. It is a fact that
there are significant variations amongst the factors that
influence the health of European citizens [10–12]. These
health variations are socially and spatially patterned, and
in many cases their drivers can be traced to broader
determinants such as socio-economic [4] and working
conditions [5, 6], which people in Europe experience in
very unequal ways [2, 13]. To characterise the health of
the population currently living in European Union (EU)
regions, it is crucial to consider multiple health dimen-
sions that go beyond the health outcomes and include a
range of determinants outside the healthcare sector [14,
15]. This can provide an evidence-based perspective of
policies, with the potential to reduce inequalities and
promote health equity [11]. Therefore, efforts towards
developing models that combine multiple determinants
of health, engagement of diverse stakeholders, and
evidence-based policies and interventions have been
stimulated and supported in the health research area
[16], inclusively by the EU through its framework for
funding research and innovation. These measures should
be based on sound methods to enhance the potential of
monitoring health and of foreseeing the impact of pol-
icies on health equity [9, 17, 18]. In our view, ‘health
equity’ is understood here as “the principle underlying a
commitment to reduce and, ultimately, eliminate dispar-
ities in health and in its determinants, including social
determinants” [19].
With respect to population health determinants, it
is known that health inequalities are shaped by one’s
socioeconomic status, education and income level,
living conditions or the physical and built environ-
ment conditions of one’s place of residence. Given
that, these factors are preventable through policies
and the allocation of resources and variations
amongst them are deemed as inequitable and thus
recognised as injustices [20]. In particular, WHO [3,
21] has acknowledged the impact of social determi-
nants on health equity and well-being, not only by
tackling personal behaviours but also by addressing
life course stages, the broader society and the wider
macro-level context, along with governance, delivery
and monitoring systems.
Simultaneous to the discussion on the scope of health
inequities, the understanding of health has evolved sig-
nificantly [22], making the concept of health complex
and holistic [23] and requiring that ‘what’ and ‘why’ be
measured [24]. Kindig et al. [16] have suggested that, to
understand the health of a society, the fundamental
question to be asked is “how we are doing – and how we
can do better?” Population health measurements have
been recognised as one of the appropriate tools to
support public health policy-making, monitoring and as-
sessment by ensuring validity and cross-population com-
parability [9]. Summary measures built on relevant
indicators are well-known instruments to provide a com-
prehensive picture of health and well-being [25, 26], with
their multi-domain basis reflecting the complexity of
people’s health. The interconnectedness of Health in All
Policies [27], recognised in the Alma Ata Declaration on
Primary Health Care [28] and the Ottawa Charter for
Health Promotion [29], has created a new spectrum for
looking at health and implied a need for an integrated
approach to population health [25, 30]. Such an ap-
proach has the potential to guide policy-making and
inter-sectorial action to improve health and reduce in-
equalities [31].
The aim of this paper is to present the ultimate out-
puts of the EURO-HEALTHY research project – to
introduce the tools, demonstrate their capacity to meas-
ure and monitor population health across European re-
gions, and finally present their potential to inform
policy-makers and to stimulate and facilitate health
equity discussions.
This paper will be of interest to policy-makers,
researchers and those who wish to enhance their under-
standing on novel population health tools that are able
to advance and promote evidence-based policy whose ul-
timate aim is a healthier and more equitable Europe.
The EURO-HEALTHY project
The aim of the EU-funded EURO-HEALTHY project
(which stands for ‘shaping EUROpean policies to promote
HEALTH EquitY’) is to advance knowledge on policies
that offer the highest potential to promote health equity
across European regions (269 regions at Nomenclature of
Territorial Units for Statistics level 2 (NUTS 2)) and urban
areas. To achieve this goal, EURO-HEALTHY has built
tools with the capacity to synthesise evidence for policy
actions to address identified health inequalities and
inequities across Europe [32].
From the outset, the project relied upon the collabor-
ation of 15 multidisciplinary European institutions and
involved nearly 100 stakeholders in the development and
application of a sound multi-disciplinary and trans-
disciplinary approach to appraise population health
across EU regions. The structure of the project was
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based on eight Work Packages (WPs) (Fig. 1), with six
WPs being directly dedicated to the scientific work and
two WPs to project coordination (WP1) and
dissemination (WP8). Thematic WPs (WP2, 3 and 4)
conducted research to provide evidence and data on
health outcomes and health determinants, including
socioeconomic, health behaviours and lifestyle determi-
nants of health and well-being factors (WP2), environ-
mental public health risks (WP3), and healthcare access
and mortality profiles (WP4). WP6 and WP7 were
‘cross-cutting’ WPs, with the former focused on design-
ing and applying innovative, participatory processes and
multi-criteria decision analysis methods to build the
Population Health Index (PHI), and the latter on asses-
sing policies and good practices in health inequalities.
WP5 integrated evidence and data, engaging all the Con-
sortium partners, including other stakeholders, in the
construction and application of the PHI to 269 European
regions and to 9 selected metropolitan areas.
The flagship tool is the EURO-HEALTHY PHI, a
multi-dimensional and multi-level index measure
which, from the lens of health equity, evaluates EU
population health in two Determinants and Outcomes
components. The PHI is further divided into sub-
indices by area of concern, health dimension and indica-
tors, and is designed to be applied across all regions of
the 28 EU Member States [32] and to selected metro-
politan areas [33].
To enlighten the discussion on policies to promote
health equity in Europe, the PHI model was used as the
starting point to develop the EURO-HEALTHY Scenar-
ios for Population Health Inequalities in Europe for
2030 [32]. The rationale for developing the scenarios
was two-fold – policy-makers not only need reliable
tools to help them holistically evaluate the policies’ ben-
efits in terms of their feasibility and power issues, but
they must also reflect upon and assess how future events
may affect health inequalities and which policies may
produce adverse outcomes [34–36].
The bridge between academia, policy-makers and civil
society was promoted by the EURO-HEALTHY consor-
tium in two main forms – by using large-scale partici-
patory approaches in the development of the EURO-
HEALTHY PHI and of the EURO-HEALTHY scenar-
ios, and by making mapping tools available for the dis-
semination of the results of applying the PHI to
European regions amongst policy-makers and a wider
audience, including civil society. Recognising that the
Geographical Information Systems (GIS) facilitate both
the compilation, analysis and dissemination of large
and multi-dimensional information sets [37], the
project has developed a WebGIS platform called
Fig. 1 Structure of the EURO-HEALTHY project: Work Packages
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healthyregionseurope (https://healthyregionseurope.uc.
pt). This online tool allows for the space–time analysis,
monitoring and comparison of population health
(current and future) at 269 NUTS 2 European regions,
and for 9 selected metropolitan areas (Athens, Barce-
lona, Berlin, Brussels, Lisbon, London, Prague,
Stockholm and Turin).
Data and methods
The project collected and systematised a vast amount of
data for 80 indicators chosen for their relevance in asses-
sing population health in Europe at three geographical
levels – national (countries), regional (NUTS 2) and
metropolitan (for selected municipalities) – and for the
years 2000–2015. These data were aggregated in an on-
line platform accessible at https://eurohealthydata.uc.pt
that stores a wide range of data collected during the pro-
ject and available for consultation and download. It can
support researchers in their data analyses by facilitating
access to a database with multiple indicators to investi-
gate further inequalities and inequities in health across
Europe.
The construction of EURO-HEALTHY PHI
The PHI structure is based on a multi-criteria model
that was built with the MACBETH (Measuring Attract-
iveness by a Categorical Based Evaluation Technique)
socio-technical approach [38] and makes use of Multi-
Criteria Decision Analysis and value measurement
concepts, integrating the technical elements of a multi-
criteria value model and the social elements of interdis-
ciplinary and participatory processes [39].
The set of indicators used within the PHI was in-
formed via a participatory process in which experts
and other stakeholders accessed updated scientific evi-
dence and judged the relevance of indicators identi-
fied by the Consortium members within the WPs to
appraise population health at the EU regional level
[15]. A multidisciplinary group of 81 experts was in-
volved in the participatory processes, from the struc-
turing of the PHI multicriteria model (areas of
concern, dimensions and indicators) to the evaluating
phases (weights, value functions). These 51 Consor-
tium members and 30 other stakeholders reflected
not only a wide range of expertise but also Europe’s
diversity [15], as the group comprised representatives
of national, regional and local authorities, advisors
and technicians, international bodies, political parties,
healthcare professionals, and urban planners (Table 1).
The participatory processes are detailed below in the
section describing stakeholders’ involvement.
Presenting a bottom-up hierarchical structure, the PHI
provides an evidence-based approach to analyse inequal-
ities within a chained sub-index structure (Fig. 2) headed
by Health Determinants and Health Outcomes indices.
These indices are divided into ten sub-indices, corre-
sponding to the main areas of concern for population
health, namely (1) economic conditions, social protec-
tion and security, (2) education, (3) demographic change,
(4) lifestyle and health behaviours, (5) physical environ-
ment, (6) built environment, (7) road safety, (8) health-
care resources and expenditure, (9) healthcare
performance, and (10) health outcomes. These sub-
indices are further divided into health dimensions and
indicators. Each area of concern integrates a set of popu-
lation health dimensions which are independent evalu-
ation axes for appraising population health and are
made operational by one or more indicators (Table 2).
More details on the methodology applied to build
the PHI are given in Bana e Costa et al. [39] and
Santana et al. [40].
EURO-HEALTHY scenarios
Technically, the approach to building EURO-
HEALTHY scenarios required a process that would cre-
ate such scenario structures to include a large number
of drivers and combine a group elicitation method with
the Extreme-World method [41, 42]. The social side of
the approach required a combination of face-to-face
and non-face-to-face participatory processes to obtain
the views and opinions of health stakeholders and
experts. A Web-Delphi process was conducted with a
large and diverse panel of experts and other
Table 1 Composition and characteristics of the panel of experts
involved in the construction of the Population Health Index
Characteristic No.
Total 81
Gender
Male 37
Female 44
Type of panellist
Expert 51
Stakeholder 30
Field of expertise
Economics and health systems 9
Environmental health, ecological systems, sustainability 15
Epidemiology, social medicine and public health 29
Health geography, demography and sociology 28
Region of Europe
Northern Europe 16
Western Europe 18
Eastern Europe 12
Southern Europe 35
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stakeholders and was established to generate ideas for
potential causes of future changes as well as to inform
which drivers were relevant for future population
health inequalities (departing from current health in-
equalities across European regions). Drivers identified
by the panellists were complemented with future-
oriented evidence and organised under the PESTLE cat-
egories (Political, Economic, Social, Technological,
Legal and Environmental). This set of data was the
starting point from which a strategic small group
worked to organise the drivers into three scenario
structures in a (face-to-face) workshop process format.
The process was finalised by developing scenario narra-
tives for the three plausible scenario structures [42].
The detailed description of this process is available in
Alvarenga et al. [43].
Evaluating and selecting urban policies under EURO-
HEALTHY scenarios
The multi-methodology uses Multi-Criteria Decision
Analysis to appraise policies on a common basis and,
within the case study, was used to engage 33 local stake-
holders in a series of face-to-face workshops to identify
critical situations for equity in the Municipality of
Lisbon. In this process, a strategic group of 16 stake-
holders (policy-makers, health professionals, urban plan-
ners, social security practitioners, representatives of civil
society) was engaged in a 2-day decision conferencing
process to evaluate the potential of a set of policies to
improve overall health and reduce health inequities. The
impact of policies was valued according to their contri-
bution to priority intervention axes corresponding to
eight of the above-mentioned PHI areas of concern and
Fig. 2 Population Health Index structure (entailing Components, population health areas of concern, health dimensions and respective weights)
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Table 2 List of indicators included in the EURO-HEALTHY Population Health Index model, grouped by population health area of
concern and health dimension
Population health area of concern Health dimension Indicators
Economic conditions, social
protection and security
Employment Unemployment rate (%)
Long-term unemployment rate – 12 months and more (%)
Income and living conditions Disposable income of private households per capita (Euro per inhabitant)
People at risk of poverty or social exclusion (%)
Disposable income ratio – S80/S20 (ratio)
Social protection Expenditure on care for the elderly (% of GDP)
Security Crimes recorded by the police (per 100,000 inhabitants)
Education Education Population aged 25–64 with upper secondary or tertiary education attainment (%)
Early leavers from education and training (%)
Demographic change Ageing At risk of poverty rate of older people – aged 65 years and over (%)
Ageing index (ratio)
Lifestyle and health behaviours Lifestyle and health behaviours Adults who are obese (%)
Daily smokers – aged 15 and over (%)
Pure alcohol consumption – aged 15 and over (litres per capita)
Live births by mothers under the age of 20 (%)
Physical environment Pollution Annual mean of the daily PM2.5 concentrations (μg/m3)
Annual mean of the daily PM10 concentrations (μg/m3)
Greenhouse gases (total tonnes of CO2 eq. emissions per capita)
Population exposed to traffic noise – (Lden 55–59 db, during day) (%)a
Extreme weather eventsa Population affected by flooding (per 1,000,000 inhabitants)a
Built environment Housing conditions Average number of rooms per person
Households without indoor flushing toilet (%)
Households without central heating (%)
Water and sanitation Population connected to public water supply (%)
Population connected to wastewater treatment plants (%)
Waste management Recycling rate of municipal waste (%)
Land usea Population density (inhabitants/km2)a
Road safety Road safety Victims in road accidents – injured and killed (per 100,000 inhabitants)
Fatality rate due to road traffic accidents (per 1000 victims)
Healthcare resources and
expenditure
Healthcare resources Medical doctors (per 100,000 inhabitants)
Health personnel – nurses and midwives, dentists, pharmacists and physiotherapists
(per 100,000 inhabitants)
Healthcare expenditure Total health expenditure (PPS$ per capita)
Private households’ out-of-pocket expenses on health (% of total health expenditure)
Public expenditure on health (PPS$ per capita)
Healthcare performance Healthcare performance Hospital discharges due to diabetes, hypertension and asthma (per 100,000 inhabitants)
Amenable deaths due to healthcare (standardised death rate per 100,000 inhabitants)
Health outcomes Length of life (mortality) Life expectancy at birth (years)
Infant mortality (per 1000 live births)
Preventable deaths (standardised death rate per 100,000 inhabitants)
Quality of life (morbidity) Self-perceived health less than good (%)
Age-standardized disability-adjusted life year rate (per 100,000 inhabitants)
Low birth weight (%)
Lden day–evening–night noise level, PPS purchasing power standards
a Dimensions and indicators included in the Population Health Index model (conceptual) but not used in its application (adjusted) to the 269 NUTS 2 regions, due
to lack of data
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to the comparative added value of improving each of
these intervention axes. The feasibility of policies was
assessed in light of the EURO-HEALTHY scenarios.
WebGIS – healthyregionseurope
EURO-HEALTHY developed an open access user-friendly
WebGIS platform (http://healthyregionseurope.uc.pt) to
provide both data and a snapshot of European population
health over multiple dimensions and geographical scales –
at the regional level, for 269 NUTS 2 regions of the 28 EU
countries, and at the municipal level, for 540 municipal-
ities of 9 selected metropolitan areas (Athens, Barcelona,
Berlin, Brussels, Lisbon, London, Prague, Stockholm and
Turin).
The platform was built to serve not only as a visualisa-
tion tool, but also to enable the exploration and analysis
of geographical patterns of the PHI value-scores (ranging
for each indicator from 0 to 100, with 0 representing the
lowest level of population health and 100 the highest
level of population health) for the year 2014 (Fig. 3).
Results
The EURO-HEALTHY PHI can be read as a ‘composite
measure’, ‘composite index’ or ‘composite indicator’
based on a clear conceptual framework, integrating the
different elements of population health and capable of
considering multiple aspects delivered as an aggregated
score. The EURO-HEALTHY project sustained the
added-value of developing such a holistic measure, inte-
grating indicators from multiple health dimensions
across EU countries, regions and selected metropolitan
areas [32].
The PHI follows a population health approach as de-
scribed and popularised by Kindig and Stoddart [44],
taking the view that population health should be
measured considering the “health outcomes and their
distribution within a population, the patterns of determi-
nants that influence such outcomes, and the policies that
influence the optimal balance of determinants”. The
underlying assumption focuses on improving the health
of the population rather than that of individuals, and on
reducing health inequalities through actions that target
the determinants of health.
In line with this, the EURO-HEALTHY PHI was de-
signed as a comprehensive tool to enable evidence-based
policy-making by (1) allowing for the measuring and
monitoring of the overall health and well-being of re-
gional European populations; (2) accounting for the
multi-dimensional nature of health determinants; (3)
foreseeing and discussing the impact of multi-level
policies that can influence population health and geo-
graphical health inequalities in Europe; and (4) providing
a basis for multilevel policy dialogue on health and
health equity.
The EURO-HEALTHY PHI was applied to analyse
population health and identify geographical health
inequalities in 269 NUTS 2 level regions, 9 selected
metropolitan areas (Athens, Barcelona, Berlin,
Brussels, Lisbon, London, Prague, Stockholm and
Turin) and in 2 case studies (Lisbon and Turin). The
PHI outputs offer different ways of looking at health
inequalities in Europe. For instance, they provide op-
portunities to analyse how European Structural and
Investment Funds can be used to reduce population
health inequalities and enable policy dialogue at na-
tional and regional levels [45]. In addition, when the
PHI is regularly updated, it becomes a valuable re-
source for policy monitoring and evaluation.
In the interest of developing foresight tools for policy
improvement, a key goal of the project was to build
EURO-HEALTHY scenarios to inform potential drivers
with a means to affect future health and health inequal-
ities across European regions and to understand the
extent to which future evolutions can be triggered by
today’s actions [46]. Following these objectives, EURO-
HEALTHY produced health inequalities scenarios for
2030 through a novel socio-technical approach that
combined present and future-oriented evidence with the
perspectives and values from a diverse group of experts
and other stakeholders across Europe within a struc-
tured process.
Accordingly, three EURO-HEALTHY scenarios for
2030 were produced [42] – (1) the ‘Failing Europe’
scenario as a worst-case (although plausible) scenario,
including all driver configurations leading to enlarging
the population health inequalities; (2) the ‘Sustainable
Prosperity’ scenario based on the best-case scenario
structure, including all configurations leading to decreas-
ing the population health inequalities; and (3) the ‘Being
Stuck’ scenario, which reflects a situation where the EU
and EU Member States maintain the status quo and are
‘stuck’ with those specific difficulties that keep Europe
from moving forward such as generating new consensus
or common policies.
Two scenarios – ‘Sustainable Prosperity’ and ‘Failing
Europe’ – were tested in a real exercise conducted
within the scope of the Lisbon case study to formulate
and assess policies to improve urban health inequalities,
which we further describe.
Aligned with the methods used to build the PHI
and scenarios, EURO-HEALTHY developed a trans-
parent multi-methodology to inform policy appraisal
and selection. Underlying the multi-methodology is
(1) the recognition of the importance of policy-
makers and other stakeholders’ engagement in the
policy appraisal process; (2) the need for policy selec-
tion accounting for policy feasibility and other imple-
mentation issues; (3) the acknowledgment that
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Fig. 3 (See legend on next page.)
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foreseeing the impact of policies involves uncertainty
and that scenarios are a tool to deal with uncertainty
in the policy appraisal process; (4) the recognition
that health public policies aim to achieve multiple ob-
jectives, including maximising health gains and redu-
cing inequalities; and (5) the acknowledgment that
indices are powerful tools for assessing the impact of
policies.
The application of this multi-methodology to evaluate
local policies in the Lisbon case study was successful in
illustrating, firstly, which policies have higher potential
to improve overall health and, secondly, how the local
policies’ feasibility can change according to different
European scenarios. Specifically, European scenarios
have been shown to have an important impact on the
capacity of the Lisbon municipality to implement certain
policies and to raise awareness of those individuals
involved in the decision-making process as to the
policies’ risks and opportunities [47]. Furthermore, the
participatory component of the multi-methodology dem-
onstrated how interaction between local stakeholders
can be facilitated given the emphasis on the different
perspectives on health equity and its indicators within
structured and transparent formats.
The WebGIS offers a set of dynamic features for
users exploring population health in Europe (1) analys-
ing and comparing the regional performances and
value-scores in an aggregated and disaggregated way,
following a value tree index structure (with sub-indices
for components, areas of concern, dimensions and indi-
cators) (Fig. 3, maps a and b), and (2) simulating
changes in the performances of indicators (as if consid-
ering the impact of policies) to understand the potential
effect of policies on the regional population health
scores and thus on regional inequalities across Europe.
For instance, the simulator web functionality provides
evidence on the actual inequalities across EU regions
and allows the user to change one or a set of indicators’
performances, considering different policy strategies
(e.g. reducing the levels of PM10 of all regions whose
current performances are above 20 μg/m3 to the refer-
ence value of 20 μg/m3) and generating new population
health scores (Fig. 3, map c). In addition, maps show
the regions and countries that benefit from a given pol-
icy or from a package of policies.
These WebGIS platform functionalities support the
transfer of knowledge from scientists to policy-makers
and to the public in general, as it communicates funda-
mental information in a user-friendly way to help those
concerned with understanding and reducing health gaps
in Europe.
The WebGIS is a web database platform that was specif-
ically designed to support researchers in data analysis and
to investigate inequalities and inequities in health across
EU regions. The complementary eurohealthydata plat-
form is accessible at https://eurohealthydata.uc.pt and is
password protected (passwords assigned upon request via
the website) and aggregates 80 indicators collected at 3
geographical levels – national (countries), regional (NUTS
2) and metropolitan (municipalities) – for the period
2010–2015. This web-based data platform has the capacity
to store and download all data (metadata, alphanumerical
and geographical data) collected in the project. Both plat-
forms were built using open source software.
Discussion
From its inception, the project was conceived to repre-
sent widely shared principles of the EU with respect to
economic, social and territorial cohesion as a way to
promote the well-being of all EU citizens. The produc-
tion of reliable evidence to inform the European efforts
to obtain these values provide the basis of the research
activities. We herein emphasise the key features and the
potential for learning from EURO-HEALTHY research.
Evidence and tools supporting policy-makers and
stakeholders to address health inequalities on multiple
scales
The information generated by the PHI not only allows
for a deeper understanding of which factors influence
the overall health of a specific EU region or groups of re-
gions, but it can also provide guidance for the evaluation
and selection of policies with the greatest potential to
address inequalities between regions.
The regional population health scores can be analysed
in various forms, e.g. by grouping regions with a similar
profile in terms of performance in a specific dimension
or indicator (clusters), by measuring statistically signifi-
cant differences between groups of regions (e.g. by
categories of regions eligible to receive Cohesion Policy
(See figure on previous page.)
Fig. 3 Screenshots from the WebGIS healthyregionseurope. Note: Map a shows the tab view for the Population Health Index (PHI) indicators, in terms
of performance (illustrative example is presented for the indicator “Annual mean of the daily PM10 concentrations” where the performance of one
region – Śląskie, Poland – is shown). Map b shows the tab view for the PHI model, in terms of value-score (illustrative example is presented for the
health dimension “Pollution” where the value-scores of two regions – Śląskie, Poland, and Stockholm, Sweden – are being compared). Map c shows
the tab for the Simulator (illustrative example is presented for the simulation conducted in the health dimension “Pollution”, where a change of
performance on the indicator “Annual mean of the daily PM10 concentrations” generated new value scores; a specific example of value improvement
can be seen for the region Śląskie – Poland)
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funds) and by identifying which dimensions constitute
areas for improvement across all EU regions. By utilising
the Health Determinants Index and its dimensional sub-
indices, policy-makers at different levels of decision-
making (European, national and regional) are able to
examine the relationships between health determinants,
health outcomes and policies from different sectors. The
PHI works as a basis for understanding which policies
(from different sectors and competing for resources)
have the highest potential to improve health (e.g. in a
specific region or group of regions of the same country)
and to decrease health inequalities (e.g. between regions
of the same country or between EU regions). Further
analysis can also be done on what policies have contrib-
uted to the current population health scores in selected
regions.
From the perspective of policy evaluation, the PHI
multicriteria model can be used both as an instru-
ment to design and select policies on an ex ante basis
as well as ex post, monitoring the impact of policies
across time and to perform cost-effectiveness analyses.
This would require a dynamic update of the PHI,
which implies feeding the model with up-to-date data
and, potentially, the inclusion of new indicators
reflecting novel research and evidence pointing out
other factors linked to local priorities or global
trends. It should be noted that the updating of the
PHI model offers opportunities but also presents cer-
tain constraints to be overcome, namely those related
to data availability in some dimensions. Data gaps at
the regional level on several indicators led to some
adjustments between the conceptual model and the
model implemented and available via the WebGIS.
Issues with availability and quality of the indicator
data at sub-national levels should be fundamentally
addressed in order to obtain the full potential of this
tool [48].
One of the strengths of using the PHI and the
methods employed in its construction is the involvement
of stakeholders and experts whose knowledge is benefi-
cial to the robustness and applicability of the results. In-
novative policy design, using the PHI in conjunction
with the EURO-HEALTHY scenarios, can be introduced
to tackle health inequalities across multiple domains and
levels. Together, these tools inform on current popula-
tion health variations in the EU, on the multiple factors
underlying those variations (drivers) and on how overall
health will evolve if those factors are changed positively
or negatively.
The PHI results can identify what the problems are
and where action is most needed. Policy-makers and
stakeholders can easily access this information
through a WebGIS platform that communicates the
PHI in a very interactive way, pointing to health
inequalities between regions and across multiple
dimensions.
EURO-HEALTHY considered that maps displaying
health information in a simple, clear way are important
analytic tools for decision-makers in their efforts to sup-
port planning, develop equitable policy and assess equity
[49]. GIS have become tools of considerable usefulness
[50] in monitoring diseases [51], detecting the differ-
ences and similarities in population health [52], and in
enabling overall understanding of health distribution in
the population [53] and of the relationship between
health and space [54, 55]. The adoption of a place-based
approach and a multi-methodology (including scenarios)
to evaluate local policies in the Lisbon case study
unlocked the potential for transformative change in the
way of formulating and evaluating policies across sectors
that go beyond the health sector. This experience could
be transferred to other cities with the necessary adjust-
ments in terms of panel formation, indicators and the
policies at stake.
Stakeholders’ involvement through large-scale
participatory processes
At the heart of the project was the force of continued
stakeholder engagement alongside innovative methods
to develop the EURO-HEALTHY tools. Over a 3-year
journey, the project has, in a transdisciplinary way, inte-
grated more than 150 stakeholders and experts from 15
European countries, with these being involved directly in
research design from the beginning of the project. This
process of sharing ideas, bringing European countries to-
gether, and learning from each other strengthened the
solidarity of the project’s action. Stakeholders were iden-
tified by the EURO-HEALTHY consortium partners and
selected based on a variety of characteristics, namely (1)
their ability to influence policy at various decision-
making levels (national, regional and metropolitan), (2)
their scope for intervention (public sector, private sector
and civil society), (3) their area of work (e.g. environ-
ment, public health, urban planning, groups at risk), and
(4) geographic location (meant to reflect Europe’s diver-
sity) [56].
Stakeholders and researchers were regularly involved
in the project research activities to develop the EURO-
HEALTHY tools, produce knowledge and evidence, and
mostly build a bridge of communication between scien-
tists and policy/decision-makers [56]. Web-based Delphi
panels, decision conferences and face-to-face workshops
were successful formats for interacting with stakeholders
and researchers to collect their insights and views on (1)
the relevant indicators to evaluate and monitor regional
European population health (Web-Delphi for selecting
indicators for the PHI) [15]; (2) the importance of clos-
ing gaps in the performance of distinct indicators across
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EU regions (Web-Delphi for weights) [39]; (3) added
value to population health from improving performance
along the indicator range (Web-Delphi for value func-
tions) [39]; (4) drivers for future population health
inequalities scenarios (Web-Delphi for scenario building)
and for population health inequalities scenarios in Eur-
ope (workshops) [42]; and (5) formulation and evalu-
ation of policies with the highest potential to improve
population health and to reduce inequities at the urban
level, namely in the Lisbon and Turin case studies
(workshop and decision conferences) [35].
EURO-HEALTHY web-based Delphi participatory
processes have proved to be a convenient and time-
efficient method for multi-level stakeholders. This has
also been confirmed in other health-related studies [14]
and has served to generate useful information to help
smaller groups in the construction of the EURO-
HEALTHY PHI model and EURO-HEALTHY scenarios,
and in the evaluation of policies.
The involvement of a transdisciplinary panel of re-
searchers and stakeholders in the process of shaping the
EURO-HEALTHY tools added diverse points of view,
which consequently validated the holistic perspective of
looking at health. This approach was crucial in securing
sustainable engagement from stakeholders in the project
activities, enhancing their understanding of the drivers
of health inequalities in Europe, and strengthening their
will, interest and power to promote change via their fu-
ture decisions [15]. It served as a catalyst for an ex-
tended dialogue as to which policies produce the highest
benefit in promoting more equitable and healthy envi-
ronments at different levels (national, regional and
local), while bearing in mind the impact that different
policies can have on population health and health equity
[57]. In this sense, the project represented “the science of
stakeholder engagement in research” – a term coined by
Goodman and Thompson ([58], p. 489), where they
strongly advocate for enhancing efforts towards mean-
ingful stakeholder engagement that will contribute to
both research synergy and achieving results that would
otherwise be impossible via isolated actions alone. The
Lisbon and Turin case studies have shown that stake-
holder engagement is fundamental to promoting consen-
sus and establishing priorities for intervention at the
local scale to reduce unjust health inequalities in trans-
parent formats [32].
‘Learning networks’ to reduce health inequities across
Europe
It is a stated challenge for the EU to take action centrally
to address the highly localised, spatially patterned health
issues that are often heavily shaped by local and regional
circumstances. Featuring broad-ranging data on a variety
of countries, regions and metropolitan areas, and
gathered and utilised in one measure, the PHI facilitates
the joint learning process, encourages conversation and
dialogue, and supports the identification of relevant part-
ners (regions) tackling similar problems. In this context,
the evidence provided by the project, and specifically by
the PHI, has the potential to create windows of oppor-
tunity, ones which could evolve into the establishment
of ‘learning networks’ – mechanisms supporting in-
formed and localised actions on multiple health determi-
nants to mitigate the unjust inequalities in a multi-
dimensional environment. This process would assist in
advocating, stimulating and facilitating those actions that
can promote equity in European health through promot-
ing knowledge transfer between scientists and decision-
makers. The creation of these ‘learning networks’,
whether between regions and/or cities, would highly
benefit from EU funding, namely via European Struc-
tural Investments Funds, which provide the adequate
framework to boost synergies and implement such
regional networking. This would create greater oppor-
tunities for regional convergence and for documented
good practices with the potential to improve other low-
performing localities. This value takes on significant
meaning in decision-making and decision support to im-
prove equity and facilitate successful action.
Further research
Further research on developing technological platforms
for expert and stakeholder engagement should be
emphasised given the relevance of considering different
points of view as well as disseminating scientific evi-
dence and reliable data. In this context, the Web-Delphi
participatory processes applied in the EURO-HEALTHY
project have proved to be an inclusive and effective way
to collect information from an expanded number of geo-
graphically dispersed experts and stakeholders. Yet, a
certain amount of sensitivity bias related to the compos-
ition of the panels was expected due to the different
backgrounds and geographical contexts in which experts
and stakeholders live and work. In theory, the experts’
judgments may not be in line with the context where
the decision-making process is to be integrated. There-
fore, in order to reduce the expert’s bias in future stud-
ies, this issue should be addressed.
The development and application of the PHI model at
other geographic levels (e.g. local) and settings (e.g.
North America, Africa) requires further research on
adjusting the model to the specific contexts. Conducting
participatory processes with local panels of stakeholders
and other experts, for example, by defining adequate in-
dicators that reflect the realities of local conditions and
the respective weights and value functions, are consid-
ered imperative.
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The EURO-HEALTHY PHI may also serve as a start-
ing point and useful tool to initiate a dialogue with local
stakeholders and policy-makers about which priority
intervention fields each locality should address in the
interest of improving overall population health. This
would be possible by further extending the evaluation of
policies conducted in the Lisbon and Turin case studies
to other case studies and by creating tools and know-
ledge to integrate policy evaluation with uncertainty and
scenarios.
The EURO-HEALTHY tools were built under the
points of view and perspectives of a panel of researchers
and stakeholders taking into account the available data
at the present time. In the future, it is absolutely neces-
sary to continuously monitor data on health determi-
nants and health outcomes in order to update the
models of PHI and scenarios. The set of relevant indica-
tors and respective weights could then change, reflecting
alterations driven by policies or new societal challenges.
Explicit attention should be given to social, economic
and environmental determinants that shape health
equity. These indicators are fundamental to inform
policy and monitor its effectiveness. Currently, despite
significant advances in data harmonisation at the EU
level (e.g. Eurostat), there is still room for improved data
to monitor and assess specific health determinants [48]
that shape health outcomes at different geographical
levels in a comparable way [59]. The benefit of using the
PHI in the future will be accentuated if there is greater
alignment of the data collected from different data
sources (in the current PHI not all data were available at
the same time and spatial resolution). Efforts should be
intensified to collect and harmonise data at the sub-
national level with the goal of narrowing the gaps in data
amongst and within the EU Member States [48].
Conclusions
The EURO-HEALTHY project achieved its goal in pro-
viding a comprehensive evaluation of health inequalities
across Europe and ultimately incorporating innovative
ways of supporting the analysis and selection of policies
with the potential to shape healthier settings. The pro-
ject has delivered tools – mostly based on the PHI –
which are scientifically and methodologically robust and
innovative and yet simple and user-friendly. The open-
access WebGIS platform offers an easy and interactive
way to visualise and analyse the population health varia-
tions across EU regions and metropolitan areas in a way
that can enable more informed health advocacy across
Europe. The highly participatory component proved to
be paramount for integrating multiple views and facili-
tating information exchange amongst the involved stake-
holders and experts.
At the same time, the data and evidence that was gen-
erated to feed these tools provide opportunities for com-
parability across different geographical scales, which is
an appeal to reinforce efforts to collect, harmonise and
use data, namely at sub-national level.
The EURO-HEALTHY tools should be used, particu-
larly by policy-makers, to support decision-making in re-
lation to those policies with the highest potential to
improve health equity in Europe and to further monitor
the impact of the policies of today as well as those of the
future.
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